My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Edwards Lifesciences (NY:EW)

86.75 -0.07 (-0.08%)

Official Closing Price Updated: 7:00 PM EST, Nov 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

EDWARDS LIFESCIENCES CORP (NYSE:EW) Shows Strong Technicals and a High-Quality Breakout Setup ↗

Today 5:11 EST

Edwards Lifesciences (EW) stock shows strong technical momentum and a high-quality breakout setup, poised for a potential move above key resistance.

Via Chartmill

Goodbye Nvidia, Hello Microsoft: Halvorsen's Big Q3 Hedge Fund Pivot ↗

November 17, 2025

Andreas Halvorsen of Viking Global Investors' portfolio Q3 changes included exits from Amazon, Nvidia and Qualcomm.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 11, 2025

Via Benzinga

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

Nvidia, Citi, AT&T, Lucid, Edwards Sciences: What Sparked Heavy After-Hours Trading In These 5 Stocks? ↗

August 22, 2025

Via Stocktwits

Here's How Much $100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth Today ↗

November 04, 2025

Via Benzinga

Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday? ↗

October 31, 2025

Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap giants kept the rally momentum alive.

Via Benzinga

EDWARDS LIFESCIENCES CORP (NYSE:EW) Beats Q3 Estimates and Raises Full-Year Guidance ↗

October 30, 2025

Edwards Lifesciences beats Q3 earnings, raises full-year guidance on strong structural heart portfolio growth and robust TAVR & TMTT sales.

Via Chartmill

Edwards Lifesciences Pops As Third-Quarter Beat Lifts 2025 Guidance ↗

October 30, 2025

Edwards Lifesciences stock jumped late Thursday after the medtech company boosted its 2025 outlook after beating quarterly calls.

Via Investor's Business Daily

A Preview Of Edwards Lifesciences's Earnings ↗

October 29, 2025

Via Benzinga

Nvidia To Rally Around 37%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

October 29, 2025

Via Benzinga

This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday ↗

October 29, 2025

Via Benzinga

Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday? ↗

October 30, 2025

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome...

Via Benzinga

Topics Economy

These S&P500 stocks have an unusual volume in today's session ↗

October 28, 2025

Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below.

Via Chartmill

Exploring the top movers within the S&P500 index during today's session. ↗

October 27, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.

Via Chartmill

Here's How Much $100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today ↗

October 10, 2025

Via Benzinga

Wealth Manager Doubles Down on Adobe, According to Recent SEC Filing ↗

October 09, 2025

Via The Motley Fool

Topics Regulatory Compliance

Wealth Manager Takes Big New Stake in Visa, According to Latest Filing ↗

October 09, 2025

Via The Motley Fool

Topics Regulatory Compliance

Which S&P500 stocks are gapping on Wednesday? ↗

October 08, 2025

Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Wednesday to uncover the stocks that are gapping in the S&P500 index.

Via Chartmill

Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 20 Years ↗

September 29, 2025

Edwards Lifesciences (NYSE: EW) has outperformed the market over the past 20 years by 7.57% on an annualized basis producing an average annual return of 16.53%. Currently, Edwards Lifesciences has a...

Via Benzinga

Analyst Expectations For Edwards Lifesciences's Future ↗

September 22, 2025

Via Benzinga

Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings ↗

September 09, 2025

One was recently acquired by a much bigger company.

Via The Motley Fool

Topics Artificial Intelligence Energy

3 Healthcare Pathbreakers With Long-Term Tailwinds ↗

September 01, 2025

These three firms in the fast-changing healthcare sector stand out to analysts for their strong product lineups, defensible technology, and notable pipelines.

Via MarketBeat

Israel Englander's Millennium Goes All-In On Crypto And Healthcare While Rebalancing Big Tech Bets: Bitcoin ETF And Palantir Stakes Soar In Q2 ↗

August 27, 2025

Millennium Management's Q2 2025 13F reveals big bets on crypto (IBIT, PLTR) & healthcare (EW, INSM), with tech rebalancing. Read key changes!

Via Benzinga

Topics ETFs

Here's How Much $100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth Today ↗

August 26, 2025

Via Benzinga

If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today ↗

August 20, 2025

Via Benzinga

Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings ↗

August 11, 2025

A longtime leader in financial services tops the list.

Via The Motley Fool

Deal Dispatch: Performance Food Group And Claire's Lead A Week Of Big Auctions, Retail Woes ↗

August 08, 2025

Performance Food rejects offer; Lufthansa drops Air Europa bid; NFL inks deal with ESPN; Claire's files bankruptcy amid retail struggles.

Via Benzinga

Topics Bankruptcy

FTC Sounds Alarm On Edwards' Attempt To Corner Heart Device Market ↗

August 08, 2025

The FTC complaint alleges that if Edwards acquires JenaValve, it would gain control over the two most advanced TAVR-AR devices.

Via Benzinga

Edwards Lifesciences Stock: Likely To See Sluggish Price Action Through 2027 ↗

August 06, 2025

Edwards Lifesciences may avoid bearishness but is likely to trade sluggishly through 2027, as key cycle phases signal limited upside potential.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.